背景腹主动脉瘤(AAA)是一种危险的疾病,其特征是腹主动脉异常增大。动脉瘤的严重程度和症状的存在决定了必要的监测或治疗以防止潜在的死亡。本研究的目的是评估血管腔内修复术(EVAR)的围手术期死亡率和长期预后。患者和方法这是一个描述性的,回顾性,观察性研究。我们检索了2015年1月至2023年1月在GlanClwyd医院接受EVAR的AAA患者的数据。研究样本包括诊断为孤立性AAA的患者,有或没有髂支受累,根据年龄等因素被认为适合EVAR的人,合并症的存在,条件的复杂性,既往手术史,满足指示标准,耐心的欲望。数据采用SPSS统计软件进行分析,版本21.0(IBMCorp.,Armonk,NY).结果研究了22例患者。患者中EVAR的结果为内漏28.4%(n=63);迁移1.4%(n=3);堵塞0.5%(n=1);折叠0.5%(n=1);围手术期死亡率1.4%(3);其他并发症,如进入部位或急性肾损伤为1.4%(n=3)。然而,大多数患者均未出现并发症,66.7%(n=148)。在评估可能影响结果的变量后,我们观察到ASA等级,合并症,干预指征对结局有显著影响(P值分别为0.000,0.048和0.014).结论研究结果表明,当EVAR由熟练的团队遵循适当的标准进行时,结果是最优的。围手术期死亡率为1.4%。此外,与国际数据相比,我们显示了令人满意的并发症发生率.
Background Abdominal aortic aneurysm (AAA) is a dangerous disorder characterised by abnormal enlargement of the abdominal aorta. The severity of the aneurysm and the presence of symptoms determine the necessary monitoring or treatment to prevent potential fatalities. The objective of this study is to estimate the perioperative mortality and long-term outcome of endovascular abdominal aneurysm repair (EVAR). Patients and methods This is a descriptive, retrospective, observational study. We retrieved the data of the AAA patients who underwent EVAR at Glan Clwyd Hospital from January 2015 to January 2023. The study sample consisted of patients diagnosed with isolated AAA, with or without iliac branch involvement, who were deemed suitable for EVAR based on factors such as advanced age, presence of comorbidities, the complexity of the condition, history of prior surgery, fulfillment of indication criteria, and patient desire. The data was analysed using SPSS statistical software, version 21.0 (IBM Corp., Armonk, NY). Results Two hundred and twenty-two patients were studied. The outcome of the EVAR among the patients was endo-leak 28.4% (n = 63); migration 1.4% (n = 3); blockage 0.5% (n = 1); infolding 0.5% (n = 1); perioperative mortality 1.4% (3); and other complications like access site or acute kidney injury were 1.4% (n = 3). However, no complications were reported in most of the patients, 66.7% (n = 148). Upon evaluating the variables that could affect the outcome, we observed that the ASA grade, comorbidities, and the indication of the intervention had a significant effect on the outcome (P values = 0.000, 0.048, and 0.014, respectively). Conclusion The findings demonstrate that when EVAR is performed by a skilled team adhering to proper criteria, the results are optimal. The mortality rate during the perioperative period was 1.4%. Furthermore, we have shown a satisfactory rate of complications when compared to international data.